Wall Street is grinding higher midday Wednesday, with the S&P 500 up roughly 0.3-0.5% and the Nasdaq adding about 0.6% as markets attempt to stabilize after two brutal sessions. But beneath the surface, the picture is more complex: quantum momentum stocks are reversing sharply, and all eyes are on Micron (MU) earnings after the closing bell.

MU, High Stakes and High Anxiety

Micron is trading around $1,043, down about 0.8% intraday, following a stunning 13% crash on Tuesday that wiped out months of gains. The options market is still pricing a ±11% swing after earnings, one of the most binary events of the quarter.

Expectations remain elevated, revenue north of $34 billion and EPS around $20, but Tuesday's selloff has injected fresh uncertainty. Analysts warn that MU needs to deliver a strong Q4 outlook to justify its multiples after the recent pullback.

"The entire session is just noise waiting for Micron," one floor trader noted. "Everyone is positioned for the move after the bell."

Quantum Names Reverse Sharply

The quantum computing rally is taking a midday breather, and then some. Quantinuum (QNT) is down 6.6% to ~$72, erasing most of the 13.5% pre-market surge. Infleqtion (INFQ) has fallen 11% to ~$14, a sharp reversal from the morning's Trump-administration-policy-fueled highs.

For day traders, it's a textbook lesson in momentum volatility: what runs 15% at the open can vanish within hours. Traders who bought the pre-market surge saw double-digit swings in both directions by lunchtime.

NVDA Tests $200, VRNS and VKTX Hold Gains

NVIDIA (NVDA) is trading near $200-201, up about 0.4% in a choppy session. The $200 level is holding as a key technical support. Options flow is being closely watched for directional clues into the close.

Varonis Systems (VRNS) is hovering around $35-36 after Tuesday's 11-16% jump on Bloomberg's report of potential sale talks with Blackstone, Thoma Bravo, and Vista Equity Partners. The stock gapped up pre-market but gave back some gains, a classic "buy the rumor" pattern in M&A situations.

Viking Therapeutics (VKTX) is showing continued strength, up 5.9% to ~$36.86 on obesity pipeline momentum and Phase 1 progress for its amylin agonist.

Macro Picture: Oil Falls, VIX Eases

The broader market is in recovery mode with measured gains. Oil prices continue to slide, supporting risk appetite, while bond yields are stable. The VIX has ticked down from 19.5 toward the 18.5-19 range, though it remains elevated relative to last week's 17.28, reflecting lingering uncertainty into the MU print.

The Bottom Line

Today's session has two stories running in parallel: a cautious tech rebound in blue-chip names, and sharp mean-reversion in the hot quantum plays. Day traders are having to stay nimble, what worked at the open hasn't held by midday. The session's true direction won't be known until Micron's numbers cross the tape after the bell.